Your browser doesn't support javascript.
Post-COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia.
Garout, Mohammed A; Saleh, Saleh A K; Adly, Heba M; Abdulkhaliq, Altaf A; Khafagy, Abdullah A; Abdeltawab, Magda R; Rabaan, Ali A; Rodriguez-Morales, Alfonso J; Al-Tawfiq, Jaffar A; Alandiyjany, Maher N.
  • Garout MA; Community Medicine and Pilgrims Health Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Saleh SAK; Biochemisty Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Adly HM; Oncology Diagnostic Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Abdulkhaliq AA; Community Medicine and Pilgrims Health Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Khafagy AA; Biochemisty Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Abdeltawab MR; Community Medicine and Pilgrims Health Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Rabaan AA; Medical Microbiology and Immunology Department, Aim Shams University, Cairo, Egypt.
  • Rodriguez-Morales AJ; Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, 31311, Saudi Arabia.
  • Al-Tawfiq JA; College of Medicine, Alfaisal University, Riyadh, 11533, Saudi Arabia.
  • Alandiyjany MN; Department of Public Health and Nutrition, The University of Haripur, Haripur, 22610, Pakistan.
Infection ; 50(6): 1431-1439, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-1748391
ABSTRACT

INTRODUCTION:

Recent studies investigated the endurance of symptoms and occurrence of complications three months after SARS-CoV-2 infection. This study aims to examine the prevalence, variation, and severity of continual symptoms in the post-COVID-19 using a single-center questionnaire.

METHODS:

The questionnaire was distributed among population in Saudi Arabia who recovered from COVID-19 between April 1, 2020 and December 31, 2021.

RESULTS:

A total of 744 participants completed the questionnaire, 318 (42.8%) recovered less than 3 months, 75 (10.1%) recovered 3-6 months, while 351 (47.2%) recovered more than 6 months. About half of the participants 353 (47.5%) had incessant symptoms and of those patients, more than half had two or more symptoms. Common symptoms included fatigue 189 (25.4%), headache 118 (15.9%), and myalgia 63 (8.5%). Of the participants, 189 (21.4%) experienced continual symptoms including anxiety in 98 (13.2%) and depression in 70 (9.5%).

CONCLUSION:

The current study showed a high proportion of individuals with long-COVID-19 symptoms. Thus, proper assessment of the individuals in the post-recovery period can guide the patients to the relevant clinics for rehabilitation. Moreover, there is a great importance to decrease COVID-19 infection, populations should be targeted to boost vaccine efficiency.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study / Qualitative research Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Infection Year: 2022 Document Type: Article Affiliation country: S15010-022-01788-w

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study / Qualitative research Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Infection Year: 2022 Document Type: Article Affiliation country: S15010-022-01788-w